about
Genome-wide association study of intracranial aneurysm identifies three new risk lociGenome-wide association study reveals genetic risk underlying Parkinson's diseaseAiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal StudiesProdromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedTime to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.Mutation analysis of the neurofilament M gene in Parkinson's diseaseThe transcription factor PITX3 is associated with sporadic Parkinson's diseaseLoss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's diseaseIllicit stimulant use is associated with abnormal substantia nigra morphology in humansGDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaEvidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasImpaired trunk stability in individuals at high risk for Parkinson's diseaseDiscovery of new molecular subtypes in oesophageal adenocarcinomaComprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database."Cueing" for Levodopa-Induced Dyskinesias in Parkinson's DiseasePost-cueing deficits with maintained cueing benefits in patients with Parkinson's disease dementia.Clinical characteristics with an impact on ADL functions of PD patients with cognitive impairment indicative of dementiaGlobal, Yet Incomplete Overview of Cohort Studies in Parkinson's disease.Phosphorylated α-synuclein in Parkinson's disease.Friedreich ataxia: dysarthria profile and clinical data.Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.Therapeutic strategies for Parkinson's disease based on data derived from genetic research.Role of iron in neurodegenerative disorders.Transcranial brain parenchyma sonography in movement disorders: state of the art.Multiple regions of alpha-synuclein are associated with Parkinson's disease.Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.14-3-3 proteins in the nervous system.Redox imbalance.Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.Iron metabolism in Parkinsonian syndromes.Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection.Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms.Ultrasound in the (premotor) diagnosis of Parkinson's disease.Biomarkers for the early detection of Parkinson's and Alzheimer's disease.High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's diseaseTranscranial sonography in movement disorders.Transcranial ultrasound as a risk marker for Parkinson's disease.Maltose and maltodextrin utilization by Listeria monocytogenes depend on an inducible ABC transporter which is repressed by glucose
P50
Q24630663-83B5EF40-1984-437D-A30D-29E9913C6CD7Q24646654-EABE3A5E-AE0F-425D-BDD8-ED82540006F7Q24658443-D659BFCE-2AFB-417F-AA05-10B17E77347BQ26738357-F83488DC-D7B0-40F5-9FE9-492A80DF85D8Q27686808-B27C9132-76F2-49E3-94C6-0BEE311D62C2Q28212871-EC7A45A7-0AEE-43DD-9F69-E6D98EA02DB5Q28251266-4DA62502-1614-40E4-A377-548A11EF3150Q28257086-9C7000A6-30FE-4C81-8B77-C06D61A8D691Q28486143-63AA738F-2A07-4939-811F-566AADF1F726Q28550541-8759D2F5-0690-4077-9025-F62715B4632FQ28728855-F8698C52-3688-481E-B342-B42B6B744A36Q28730962-52C9D460-4B02-4200-A742-12EBA8988FD4Q28744610-8B71F331-52D6-4928-9DC9-94B0A13F2176Q29417106-C5BBA279-910B-4727-BB20-5E97CFA24FFFQ30366041-008E9CE6-7690-4693-97A0-8A919CF2DE45Q30423589-9E0A4C4E-6380-4FCA-9463-BE0CEA62D542Q30445877-02F16BD2-7353-4B64-93C6-2A91933E4B89Q30491906-E6D91A4C-C975-43E5-83C9-57746226D641Q30510167-862D2A48-6CC9-463D-B9B7-8F27115AD154Q30585816-C8245931-5D35-4A72-8C84-748817E07986Q30667454-367E1ECB-31F5-4460-AD86-23DB25EED463Q30795844-B2AADE43-4C67-4D06-B710-211BAF365B8CQ31086964-63136DFF-17A9-4845-BC04-1F7137DEB9DDQ31088283-FD89431B-2304-4F96-BB3E-2A4316399044Q31155710-29E3E398-F398-4538-B252-946FF754274FQ33183795-220DEFD6-6988-46D5-8CD6-981EA8542A3BQ33188355-06C9CB01-A457-4803-8716-8EDE87B438A0Q33206786-43A934F2-8926-40F2-95FF-6253E1C54E65Q33207941-70B88C3E-2AD6-461D-AFFF-E5E00D09C618Q33226010-8B642CA7-D1B8-497F-B439-E08FDDA1386EQ33233370-1947254C-AFF8-4B70-AA52-EA889B20590CQ33248678-0250B676-C38C-4C28-B61B-2ADA97FCE6F5Q33282375-7DBA7BE1-6162-406F-8CE0-39570ACE52CEQ33283198-840C65EF-762F-4B9B-BA4D-0714A653947FQ33319335-659C859C-45A4-4F96-8F2F-152A05AAB839Q33322663-B5AE82C4-72EB-46EB-A9E5-8546D63319FDQ33327649-5A60D8C6-C4EB-4A8B-B24E-C859459786A2Q33378406-3FC47ACB-0827-4F66-BE4A-2CDDA88EB4EBQ33514015-40E16225-4E21-43D8-B3E6-199FEF5A417BQ33570604-DC50B586-66B9-4243-835F-9D2213FE8A66
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Daniela Berg
@ast
Daniela Berg
@en
Daniela Berg
@es
Daniela Berg
@nl
Daniela Berg
@sl
type
label
Daniela Berg
@ast
Daniela Berg
@en
Daniela Berg
@es
Daniela Berg
@nl
Daniela Berg
@sl
prefLabel
Daniela Berg
@ast
Daniela Berg
@en
Daniela Berg
@es
Daniela Berg
@nl
Daniela Berg
@sl
P1006
P1006
P106
P21
P214
38145003650261340075
P31
P734
P735
P7859
lccn-nb2011006790